journal article·2017-03

Angiogenesis Assays for the Evaluation of Angiogenic Properties of Orthopaedic Biomaterials – A General Review

Wai Ching Liu, Shihui Chen, Lizhen Zheng, Ling Qin

Advanced Healthcare Materials· Volume 6· Issue 5
Publisher page

Abstract

Vascularization is an essential process in bone formation, remodeling and regeneration during both bone development and fracture repair. Vascularization remains a big challenge directly leading to the final success of newly regenerated bone. In this review, the advantages and disadvantages of different angiogenesis assays and bone defect models are described in details for investigating revascularization of materials of interest. Unlike conventional angiogenesis study with growth factors or pharmaceutical molecules performed in two‐dimension, special considerations are taken into account whether these assays can be translated for testing three‐dimensional implantable devices. Over the years, accurate and quantifiable in vitro, ex vivo and in vivo assays have been extensively demonstrated to be useful in examining how new blood vessels grow. These methods can contribute to the fundamental understanding of angiogenic properties of the materials, but a bone defect model is still pivotal in order to understand the cascade actions of angiogenesis along with bone formation. Finally, angiogenesis and osteogenesis are both complex processes interacting with each other, the choice of which assay to be performed should adequately address the clinical relevance and reflect the sequence of responses of revascularization of the test materials.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Nanoplatforms for cancer theranostics · Angiogenesis and VEGF in Cancer

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Musculoskeletal Research Laboratory Department of Orthopaedics & Traumatology The Chinese University of Hong Kong 5/F, Clinical Science Building, Prince of Wales Hospital Shatin Hong Kong SAR PR China

Pathology Center Shanghai General Hospital/Faculty of Basic Medicine Shanghai Jiao Tong University School of Medicine Shanghai PR China

Translational Medicine R&D Center Institute of Biomedical and Health Engineering Shenzhen Institutes of Advanced Technology Chinese Academy of Sciences Shenzhen PR China

Funding

Hong Kong Research Grant Council · Croucher-CAS

References (100+)

Show source-provided references
1. 10.1016/j.injury.2011.06.01110.1016/j.injury.2011.06.011 ↗
2. 10.1097/BRS.0b013e3181ccc7bf10.1097/BRS.0b013e3181ccc7bf ↗
3. 10.1126/science.849352910.1126/science.8493529 ↗
4. 10.1016/j.spinee.2014.05.02410.1016/j.spinee.2014.05.024 ↗
5. 10.1007/s10456-012-9307-810.1007/s10456-012-9307-8 ↗
6. 10.1038/nbt0705-82110.1038/nbt0705-821 ↗
7. 10.1146/annurev-bioeng-071812-15242810.1146/annurev-bioeng-071812-152428 ↗
8. 10.1016/j.copbio.2010.06.00510.1016/j.copbio.2010.06.005 ↗
9. 10.1016/j.addr.2011.03.00410.1016/j.addr.2011.03.004 ↗
10. 10.1089/10763270175333764510.1089/107632701753337645 ↗
11. 10.1002/jbm.82005061310.1002/jbm.820050613 ↗
12. 10.1038/7944910.1038/79449 ↗
13. Langer R. · 2014
14. 10.1016/j.biomaterials.2012.12.04710.1016/j.biomaterials.2012.12.047 ↗
15. 10.1038/labinvest.378025210.1038/labinvest.3780252 ↗
16. 10.1111/j.1476-5381.2012.01857.x10.1111/j.1476-5381.2012.01857.x ↗
17. 10.1172/JCI4028310.1172/JCI40283 ↗
18. 10.1016/0026-2862(77)90141-810.1016/0026-2862(77)90141-8 ↗
19. 10.1016/j.aanat.2011.10.00210.1016/j.aanat.2011.10.002 ↗
20. Haller A. · Francisci Grasset · 1763 · 2 · 400
21. Hunter J. · 1794
22. 10.1038/nrrheum.2012.110.1038/nrrheum.2012.1 ↗
23. 10.1038/nrrheum.2014.16410.1038/nrrheum.2014.164 ↗
24. 10.1088/1748-6041/9/4/04501310.1088/1748-6041/9/4/045013 ↗
25. 10.1016/j.abb.2014.07.00610.1016/j.abb.2014.07.006 ↗
26. 10.1359/jbmr.09060210.1359/jbmr.090602 ↗
27. 10.1073/pnas.15232409910.1073/pnas.152324099 ↗
28. 10.1016/S0020-1383(08)70015-910.1016/S0020-1383(08)70015-9 ↗
29. 10.1371/journal.pone.003235510.1371/journal.pone.0032355 ↗
30. 10.1172/JCI3158110.1172/JCI31581 ↗
31. 10.1038/nature1314510.1038/nature13145 ↗
32. 10.1038/nm.366810.1038/nm.3668 ↗
33. 10.1002/jcp.2468410.1002/jcp.24684 ↗
34. 10.1078/0171-9335-0030610.1078/0171-9335-00306 ↗
35. 10.1161/01.RES.0000255691.76142.4a10.1161/01.RES.0000255691.76142.4a ↗
36. 10.1016/S0966-3274(99)80008-210.1016/S0966-3274(99)80008-2 ↗
37. 10.1023/A:101225952916710.1023/A:1012259529167 ↗
38. 10.1006/mvre.2002.243410.1006/mvre.2002.2434 ↗
39. 10.1016/j.tcm.2007.12.00210.1016/j.tcm.2007.12.002 ↗
40. 10.1126/science.275.5302.96410.1126/science.275.5302.964 ↗
41. 10.1182/blood.V92.2.36210.1182/blood.V92.2.362 ↗
42. 10.1056/NEJM19971127337220310.1056/NEJM199711273372203 ↗
43. 10.1172/JCI807110.1172/JCI8071 ↗
44. 10.1002/stem.74510.1002/stem.745 ↗
45. 10.1007/s00441-006-0222-410.1007/s00441-006-0222-4 ↗
46. 10.1002/stem.128010.1002/stem.1280 ↗
47. 10.1016/j.addr.2015.03.01210.1016/j.addr.2015.03.012 ↗
48. 10.1111/j.1365-2613.2008.00633.x10.1111/j.1365-2613.2008.00633.x ↗
49. Adair T. · 2010
50. 10.1016/j.febslet.2006.04.04010.1016/j.febslet.2006.04.040 ↗
51. Santiago A. · Development · 2002 · 129 · 362110.1242/dev.129.15.3621 ↗
52. Justus C. · J. Vis. Exp. · 2014 · e51046
53. 10.1016/j.mvr.2007.05.00610.1016/j.mvr.2007.05.006 ↗
54. 10.1038/nprot.2007.3010.1038/nprot.2007.30 ↗
55. 10.1023/A:100986461356610.1023/A:1009864613566 ↗
56. Nogalski M. · J. Vis. Exp. · 2012 · 70 · e4165
57. Francescone R. r. · J. Vis. Exp. · 2011 · 55 · pii: 3040
58. DeCicco‐Skinner K. · J. Vis. Exp. · 2014 · 91 · e51312
59. 10.1038/nmeth.208910.1038/nmeth.2089 ↗
60. Carpentier G. · Image J. News · 2012
61. 10.1023/A:101221840103610.1023/A:1012218401036 ↗
62. 10.1016/j.biomaterials.2012.11.00510.1016/j.biomaterials.2012.11.005 ↗
63. 10.1146/annurev-bioeng-071811-15005210.1146/annurev-bioeng-071811-150052 ↗
64. 10.1016/j.coche.2013.11.00110.1016/j.coche.2013.11.001 ↗
65. 10.1007/s10439-010-9899-310.1007/s10439-010-9899-3 ↗
66. Nguyen D. · Proc. Natl. Acad. Sci. U. S. A. · 2013 · 110 · 6713
67. Nicosia R. · Lab. Invest. · 1990 · 63 · 115
68. 10.1111/j.1582-4934.2009.00891.x10.1111/j.1582-4934.2009.00891.x ↗
69. 10.1373/49.1.3210.1373/49.1.32 ↗
70. 10.1038/nprot.2011.43510.1038/nprot.2011.435 ↗
71. 10.1038/labinvest.378020710.1038/labinvest.3780207 ↗
72. 10.1038/nprot.2015.09710.1038/nprot.2015.097 ↗
73. 10.1016/0012-1606(74)90004-910.1016/0012-1606(74)90004-9 ↗
74. 10.1111/j.1582-4934.2006.tb00423.x10.1111/j.1582-4934.2006.tb00423.x ↗
75. 10.1002/jmor.105088010410.1002/jmor.1050880104 ↗
76. Dohle D. · J. Vis. Exp. · 2009 · 1620
77. 10.1016/S0171-2985(11)80211-110.1016/S0171-2985(11)80211-1 ↗
78. 10.1007/s10456-014-9440-710.1007/s10456-014-9440-7 ↗
79. 10.1038/cgt.2011.6810.1038/cgt.2011.68 ↗
80. Algire G. · J. Natl. Cancer Inst. USA · 1943 · 4 · 1
81. 10.1023/B:AGEN.0000037338.51851.d110.1023/B:AGEN.0000037338.51851.d1 ↗
82. 10.1016/j.nano.2010.06.00510.1016/j.nano.2010.06.005 ↗
83. 10.1111/j.1549-8719.2012.00197.x10.1111/j.1549-8719.2012.00197.x ↗
84. 10.1093/jnci/52.2.41310.1093/jnci/52.2.413 ↗
85. Muthukkaruppan V. · Science · 1979 · 205 · 141610.1126/science.472760 ↗
86. Birsner A. · J. Vis. Exp. · 2014 · e51375
87. Passaniti A. · Lab. Invest. · 1992 · 67 · 519
88. Kragh M. · Int. J. Oncol. · 2003 · 22 · 305
89. 10.1023/A:102150703148610.1023/A:1021507031486 ↗
90. 10.1016/j.ultrasmedbio.2005.12.00810.1016/j.ultrasmedbio.2005.12.008 ↗
91. 10.1007/s10456-012-9324-710.1007/s10456-012-9324-7 ↗
92. 10.1038/nrd462710.1038/nrd4627 ↗
93. 10.1023/A:102659830005210.1023/A:1026598300052 ↗
94. 10.1006/dbio.2000.999510.1006/dbio.2000.9995 ↗
95. 10.1016/j.semcdb.2014.04.03710.1016/j.semcdb.2014.04.037 ↗
96. 10.1042/bj023076710.1042/bj0230767 ↗
97. Monro P. · J. Embryol. Exptl. Morph. · 1984 · 82 · 259
98. 10.3109/1745367910899446810.3109/17453679108994468 ↗
99. 10.1002/adma.20039004710.1002/adma.200390047 ↗
100. 10.1039/b400486h10.1039/b400486h ↗